《2009USPSTF阿司匹林用于預(yù)防心血管疾病》內(nèi)容簡介：

    The USPSTF recommends the use of aspirin for menage 45 to 79 years when the potential benefit due to areduction in myocardial infarctions outweighs the poten-tial harm due to an increase in gastrointestinal hemorrhage.See the Clinical Considerations section for discussion ofbenefits and harms. This is an A recommendation.

    《2009USPSTF阿司匹林用于預(yù)防心血管疾病》內(nèi)容預(yù)覽：

    Recognition of Risk Status

    For many groups, available risk calculators can providean accurate estimate of the risk for coronary heart diseaseevents and strokes based on ***rmation about cardiovas-cular risk factors that include sex. See the Clinical Consid-erations section.

    Benefits of Preventive Medication

    The USPSTF found good evidence that aspirin de-creases the incidence of myocardial infarction in men andischemic strokes in women.

    Harms of Preventive Medication

    The USPSTF found good evidence that aspirin in-creases the incidence of gastrointestinal bleeding and fairevidence that aspirin increases the incidence of hemor-rhagic strokes.

    USPSTF Assessment

    The USPSTF concludes that, for men age 45 to 79years whose benefit due to a reduction in myocardial in-farctions exceeds the harm because of an increase in gas-trointestinal bleeding, there is high certainty that the netbenefit is substantial.

    點(diǎn)擊下載***：《2009USPSTF阿司匹林用于預(yù)防心血管疾病》